RT Journal Article
SR Electronic
T1 eSexualHealth: Preferences to Use Technology to Promote Sexual Health Among Men Who Have Sex with Men and Trans and Gender Diverse People
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.09.26.22280388
DO 10.1101/2022.09.26.22280388
A1 Abraham, Esha
A1 Chow, Eric PF
A1 Fairley, Christopher K
A1 Lee, David
A1 Kong, Fabian YS
A1 Mao, Limin
A1 Goller, Jane L
A1 Medland, Nicholas
A1 Bavinton, Benjamin R
A1 Sudarto, Budiadi
A1 Joksic, Stefan
A1 Wong, Jessica
A1 Phillips, Tiffany R
A1 Ong, Jason J
YR 2022
UL http://medrxiv.org/content/early/2022/09/27/2022.09.26.22280388.abstract
AB Objectives Gay, bisexual and other men who have sex with men (GBMSM) and trans and gender diverse (TGD) people are disproportionately affected by poorer sexual health outcomes compared to heterosexual populations. We aimed to explore the preferences of GBMSM and TGD for using eHealth for sexual health (eSexualHealth).Methods We distributed an anonymous online survey among the lesbian, gay, bisexual, transgender, intersex, queer and other people of diverse sexuality or gender (LGBTIQA+) community in Australia. The survey collected data on sociodemographic characteristics and sexual behaviours, their preferences for app/website functions and preferred HIV and sexually transmitted infection (STI) testing reminders. We used descriptive statistics to summarise the characteristics of the study population. Free-text responses were thematically analysed.Results Of 466 participants included, most identified as cisgender males (92.7%). The median age was 48 (interquartile range [IQR]: 37-56). For accessing sexual health-related information, 160 (34.6%) would use either a website or an app, 165 (32.7%) would prefer a website, 119 (25.8%) would prefer an app, and 33 (7.1%) would not use either platform. There was no significant difference between GBMSM and TGD people. Participants were most interested in information about STI clinics, HIV/STI hotspots, and sexual health education. Participants stressed the need for privacy and anonymity when using eHealth. Regarding reminders to test for HIV/STIs, receiving regular SMS was most popular (112/293, 38.2%), followed by regular emails (55/293 18.8%) and a reminder function on their phone (48/293, 16.4%).Conclusion Our study suggests a promising future for eHealth among GBMSM and TGD people. Sexual health is still a stigmatised area, and eHealth may circumvent barriers this population faces.What is already known about the topicGay, bisexual, and other men who have sex with men (GBMSM) and trans- and gender diverse people (TGD) have poorer sexual health outcomes compared to heterosexualseHealth (or digital interventions) to improve sexual health is a growing areaWhat this study addsOur survey among Australian GBMSM and TGD individuals document their preferences for using eHealth to optimize their sexual healthHow this study might affect research, practice or policyBeing aware of preferences for eHealth can inform resource allocation and future development of features wanted by target populationsCompeting Interest StatementThe authors have declared no competing interest.Funding StatementEPFC and JJO are each supported by an Australian National Health and Medical Research Council Emerging Leadership Investigator Grant (GNT1172873 and GNT1193955, respectively). CKF is supported by an Australian NHMRC Leadership Investigator Grant (GNT1172900).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was granted by the Alfred Ethics Committee (670/20).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present work are contained in the manuscript